Conquer Cancer Logo

The Global Oncology Young Investigator Award (YIA) provides research funding to early-career investigators to encourage and promote quality research in global oncology and to develop the next generation researchers to address global health needs. Global oncology refers to the application of the concepts of global health to cancer, and implies an approach to the practice of oncology that acknowledges the reality of limited resources in most parts of the world.  

The Global Oncology Young Investigator Award is intended to support:

  1. Research by investigators in low resource settings on scientific questions specific to those settings. This research has potential to offer “reverse innovation” insights that could influence practice in a wide range of practice settings.
  2. Research by investigators in high resource settings on issues in resource-limited settings. 
  3. Collaborative research (high and low resource investigators) on questions of shared concern, such as studying a cancer type that affects a small population in the U.S. but is common in another country.

Applicants are encouraged to be innovative in their research proposal. Proposed research projects could include, but are not limited to:

  • Clinical and translational research
  • Innovative care delivery
  • Prevention and palliative care
  • Implementation research
  • Health Systems, Outcomes and Economics research related to cancer control and care


Applicants must meet the following criteria to qualify for the Global Oncology Young Investigator Award:

  • Must have received a doctoral degree (including MD, PhD, MD/PhD, DO, or equivalent doctoral degrees).
  • Must apply within the last year of training or during the first two years of faculty/staff appointment or employment at the time of grant submission.
  • Not required to have oncology-specific training but should demonstrate an interest in oncology or a related branch of science and be working in an oncology setting.
  • Be an ASCO member or have submitted a membership application with the grant application. To apply for new membership, or to renew an existing membership, go to
  • Must have and be able to show proof of appropriate institutional commitment from their institution/organization/employer which includes protected time and the provision of adequate staff, facilities, and resources to the project. The applicant institution/organization/employer must have been operating for at least one full year and have an acceptable management structure and processes in place.
  • Applications may be submitted by the following entities from the U.S. and non-U.S.:
    • Higher Education Institutions
    • Research Organizations
    • Medical and Health-related Organizations
    • Government Organizations (may include medical centers and hospitals that have access to resources and infrastructure to support a research project)
    • Nonprofit Organizations (includes medical societies or associations, advocacy organizations, foundations, hospitals)
    • Non-Governmental Organizations
  • Eligible applicants are allowed to hold only one grant from Conquer Cancer at a time.

Application Instructions

All applications must be submitted in accordance to the requirements and instructions of the Global Oncology YIA Request for Proposals (RFP). All application materials must be in English and must be submitted through the Grants Portal. Paper applications or applications sent by e-mail or fax will not be accepted.

Closing Soon: Apply by September 25, 2019.

Application Deadlines

Application Open: 

July 1, 2019

Letter of Intent Deadline: 

Application Deadline: 

September 25, 2019

Award Term: 

July 1, 2020 to June 30, 2021


The Global Oncology Young Investigator Award was first awarded in 2018. As of 2019, Conquer Cancer has awarded 13 early-career investigators across the globe totaling more than $600,000.

2019 Global Oncology Young Investigator Award Recipients

Asya Agulnik, MD, MPH
St. Jude Children's Research Hospital, Inc.
Impact of Implementing a Pediatric Early Warning System (PEWS) on Hospital Outcomes in Resource-Limited Pediatric Oncology Centers
Elysia Alvarez, MD, MPH
University of California, Davis
Improving Care for Adolescent and Young Adult Oncology Patients in Mexico and Central America
Pedro Isaacsson Velho, MD
Instituto do Cancer do Estado de Sao Paulo
Nivolumab in Prostate Cancer with DNA Repair Defects (DRD)
Sebastian Mondaca, MD
Pontificia Universidad Catolica de Chile
Trastuzumab deruxtecan in patients with metastatic HER2-amplified gallbladder cancer: an international phase II trial
Sheena Mukkada, MD, MPH
St. Jude Children's Research Hospital, Inc.
Antibiotic Resistance in Global Pediatric Oncology Patients
David Pinato, MD, PhD
Imperial College London
Integrated phenotyping of the anti-cancer immune response in HIV-associated hepatocellular carcinoma: a global study.


The Global Oncology Young Investigator Award is supported by:

This list reflects commitments as of July 1, 2019.


This grant receives support that may result in a report to the CMS Open Payments website under the Physician Payments Sunshine Act. The supporting companies are required to report the amount of the grant, the names of physicians who are awarded this grant, and the names of their institutions. This information may appear on the Open Payments websiteFind out more information about the Sunshine Act and CMS Open Payments program.